Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Scott L. Childs"'
Publikováno v:
CrystEngComm. 16:8984-8993
The objectives of the study were to screen and prepare cocrystals of anti-cholesterol drug ezetimibe (EZT) with the aim of increasing its solubility and dissolution rate. Thermodynamic phase diagra ...
Publikováno v:
Molecular Pharmaceutics. 10:3112-3127
Cocrystals have become an established and adopted approach for creating crystalline solids with improved physical properties, but incorporating cocrystals into enabling pre-clinical formulations suitable for animal dosing has received limited attenti
Autor:
Scott L. Childs, Michael J. Zaworotko
Publikováno v:
Crystal Growth & Design. 9:4208-4211
Analysis of 50 Crystal Structures Containing Carbamazepine Using the Materials Module of Mercury CSD
Autor:
L. Sreenivas Reddy, Scott L. Childs, Peter A. Wood, Naír Rodríguez-Hornedo, Kenneth I. Hardcastle
Publikováno v:
Crystal Growth & Design. 9:1869-1888
A set of 50 crystal structures containing the molecule carbamazepine (CBZ) have been analyzed using the Materials module within Mercury CSD 2.0. The similarity relationships between all 50 structures were determined based on the analysis of packing m
Publikováno v:
CrystEngComm. 11:418-426
Mechanochemical liquid-assisted grinding (LAG) and sonochemical (SonicSlurry) techniques have been compared as methods to construct four model pharmaceutical cocrystals involving theophylline and caffeine as pharmaceutical ingredients and L-malic or
Publikováno v:
Crystal Growth & Design. 7:1291-1304
A crystal engineering method was used to investigate cocrystal formation of piroxicam with pharmaceutically acceptable carboxylic acids. Forming cocrystals of piroxicam can potentially result in solid forms with increased bioavailability. A total of
Autor:
Simon Bates, Christine Schertz, David Jonaitis, Leonard J. Chyall, Jeanette T. Dunlap, Aeri Park, Rex Shipplett, Scott L. Childs, Barbara C. Stahly
Publikováno v:
Expert Opinion on Drug Discovery. 2:145-154
Modern drug development demands constant deployment of more effective technologies to mitigate the high cost of bringing new drugs to market. In addition to cost savings, new technologies can improve all aspects of pharmaceutical development. New tec
Publikováno v:
Journal of pharmaceutical sciences. 104(12)
This work examines cocrystal solubility in biorelevant media, (FeSSIF, fed state simulated intestinal fluid), and develops a theoretical framework that allows for the simple and quantitative prediction of cocrystal solubilization from drug solubiliza
Autor:
Jennifer Giordano, James Cassidy, Aeri Park, Manjunath S. Shet, Edward Patrick O'donnell, Daniel P. McNamara, Anthony Iarriccio, Richard Owen Mannion, Scott L. Childs
Publikováno v:
Pharmaceutical Research. 23:1888-1897
The bioavailability of a development candidate active pharmaceutical ingredient (API) was very low after oral dosing in dogs. In order to improve bioavailability, we sought to increase the dissolution rate of the solid form of the API. When tradition
Publikováno v:
Crystal Growth & Design. 2:505-510
Crystallization studies of nabumetone (4-(6-methoxy-2-naphthalenyl)-2-butanone) performed in capillary tubes yielded a metastable polymorph. The single-crystal X-ray structure of this high-energy form is presented and compared to the structure of the